SM
Steve Meyers
Chief Commercial OfficerMr. Steve Meyers was Senior Vice President of Commercial of Ocular Therapeutix, Inc. from 2023 until February 2024 and serves as its Chief Commercial Officer from February 2024. He has over 20 years of commercial experience that includes several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets. Prior to joining Ocular Therapeutix in 2022, Mr. Meyers has served in other commercial capacities at leading biotechnology organizations including Regeneron, AbbVie, and Procter & Gamble. Most recently, Mr. Meyers served as Vice President Sales at Flexion Therapeutics in the orthopedic space. Mr. Meyers holds a B.S. from Louisiana State University in Cardio-Pulmonary Science.
Positions
- Company NameOcular Therapeutix, Inc.Stock CodeOCULPositionChief Commercial OfficerColleagues
- PUPravin U. DugelExecutive Chairman, President & CEO
- DNDonald NotmanChief Operating Officer (Leave of Absence)
- NKNadia K. WaheedChief Medical Officer
- JRJason RobinsCFO & Principal Accounting Officer
- CMCharles M. WardenLead Independent Director
- RLRichard L. LindstromIndependent Director
- LJLeslie J. WilliamsIndependent Director
- MRMerilee RainesIndependent Director
